These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 385880)

  • 41. In vitro anticandidal evaluation of novel highly functionalized bis cyclohexenone ethyl carboxylates.
    Kanagarajan V; Ezhilarasi MR; Bhakiaraj D; Gopalakrishnan M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):292-8. PubMed ID: 23426531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro postantifungal effect, adhesion traits and haemolysin production of Candida dubliniensis isolates following exposure to 5-fluorocytosine.
    Ellepola AN; Chandy R; Khan ZU
    Mycoses; 2015 Sep; 58(9):536-43. PubMed ID: 26201447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and Anticandidal Activity Evaluation of New Benzimidazole-Thiazole Derivatives.
    Kaplancıklı ZA; Levent S; Osmaniye D; Sağlık BN; Çevik UA; Çavuşoğlu BK; Özkay Y; Ilgın S
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29168743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antimycotic sensitivities of the clinically isolated candidas].
    Akgün Y; Akşit F
    Mikrobiyol Bul; 1981 Jul; 15(2):112-20. PubMed ID: 7052253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
    Ohkawa M; Tokunaga S; Takashima M; Nishikawa T; Hisazumi H; Fujita S; Wheat RW
    Chemotherapy; 1990; 36(6):396-402. PubMed ID: 2292203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine.
    Fisher BD; Armstrong D
    Antimicrob Agents Chemother; 1977 Nov; 12(5):614-7. PubMed ID: 335966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The resistance behavior of yeast isolates from defined patient groups to 5-fluorocytosine].
    Weber S; Polak-Wyss A
    Mycoses; 1991; 34 Suppl 1():77-81. PubMed ID: 1818269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of resistance of yeast-like fungi to 5-fluorocytosine].
    Pawlik B; Barylak J
    Med Dosw Mikrobiol; 1979; 31(4):277-82. PubMed ID: 575664
    [No Abstract]   [Full Text] [Related]  

  • 50. Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
    Roselle GA; Warth P
    J Antimicrob Chemother; 1983 Aug; 12(2):189-92. PubMed ID: 6311787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H; Kerridge D
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
    Sakellarides E
    Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
    Duggineni S; Srivastava G; Kundu B; Kumar M; Chaturvedi AK; Shukla PK
    Int J Antimicrob Agents; 2007 Jan; 29(1):73-8. PubMed ID: 17156978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [S-Acyl derivatives of thiosalicylamides having antifungal activity. II].
    Mazza M; Modena T; Montanari L; Pavanetto F
    Farmaco Sci; 1978 Jul; 33(7):551-8. PubMed ID: 369885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. II.--Mechanisms of resistance to 5-fluorocytosine (5-FC) and 5-fluorouracil (5-FU) (author's transl)].
    Montplaisir S; Drouhet E; Mercier-Soucy L
    Ann Microbiol (Paris); 1975; 126B(1):41-9. PubMed ID: 1211721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.
    Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
    PLoS One; 2017; 12(4):e0175269. PubMed ID: 28380072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
    Kostiala AA; Kostiala I
    J Med Microbiol; 1984 Oct; 18(2):249-54. PubMed ID: 6387127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.